by Northumbria University, Newcastle Graphical abstract. Credit: Cell Reports Medicine (2022). DOI: 10.1016/j.xcrm.2022.100717 Newly published research carried out using synthetic human bone marrow cells is paving the way for the development of safer and kinder treatments for children with leukemia. Leukemia is the most common cancer in children under 15, with over 650 children and young adults...
